{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:11:02Z","timestamp":1776082262373,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1067\/mob.2001.117416","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"S4-S12","source":"Crossref","is-referenced-by-count":58,"special_numbering":"S","title":["Current perspectives on oral contraceptive use"],"prefix":"10.1067","volume":"185","author":[{"given":"Ronald T.","family":"Burkman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee P.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Kell","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mob.2001.117416_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2307\/2991522","article-title":"Unintended pregnancy in the United States","volume":"30","author":"Henshaw","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"10.1067\/mob.2001.117416_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2307\/2991517","article-title":"Trends in contraceptive use in the United States: 1982-1995","volume":"30","author":"Piccinino","year":"1998","journal-title":"Fam Plann Perspect"},{"key":"10.1067\/mob.2001.117416_bib3","first-page":"216","article-title":"Contraceptive technology","author":"Hatcher","year":"1998"},{"key":"10.1067\/mob.2001.117416_bib4","series-title":"Ortho-McNeil Pharmaceutical 1999 annual birth control study","year":"1999"},{"key":"10.1067\/mob.2001.117416_bib5","doi-asserted-by":"crossref","unstructured":"Lippman JS, Godwin AJ, Olson W. The effect of extending the pill-free interval on follicular activity: triphasic norgestimate\/35 microgram ethinyl estradiol (EE) versus monophasic levonorgestrel\/20 microgram EE. Paper presented at: Annual Meeting of the American College of Obstetricians and Gynecologists: May 18, 1999; Philadelphia, Pa. Data on file, OrthoMcNeil Pharmaceutical.","DOI":"10.1016\/S0029-7844(99)90012-1"},{"key":"10.1067\/mob.2001.117416_bib6","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/S0002-9378(99)70364-9","article-title":"The effects on ovarian activity of a monophasic oral contraceptive with 100 \u03bcg levonorgestrel and 20 \u03bcg ethinyl estradiol","volume":"181","author":"Coney","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/09513599509160463","article-title":"The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth","volume":"9","author":"Teichmann","year":"1995","journal-title":"Gynecol Endrocrinol"},{"key":"10.1067\/mob.2001.117416_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0010-7824(95)00096-S","article-title":"Ovarian function during low-dose oral contraceptive use","volume":"51","author":"Egarter","year":"1995","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 \u03bcg and 35 \u03bcg estrogen preparations","volume":"60","author":"Rosenberg","year":"2000","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib10","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1471-0528.1993.tb14309.x","article-title":"Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 \u03bcg desogestrel and either 30 \u03bcg or 20 \u03bcg ethinyl oestradiol","volume":"100","author":"\u00c5kerlund","year":"1993","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1067\/mob.2001.117416_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(99)00026-8","article-title":"Clinical comparison of triphasic norgestimate\/35 \u03bcg ethinyl estradiol and monophasic norethindrone acetate\/20 \u03bcg ethinyl estradiol: cycle control, lipid effects, and user satisfaction","volume":"59","author":"Sulak","year":"1999","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/13625189909064008","article-title":"A comparison of cycle control with monophasic levonorgestrel\/ethinylestradiol 100 \u03bcg\/20 \u03bcg versus triphasic norethindrone\/ethinylestradiol 500-750-1000 \u03bcg\/ 35 \u03bcg: a multicenter, randomized, open-label study","volume":"4","author":"Chavez","year":"1999","journal-title":"Eur J Contraception Reprod Health Care"},{"key":"10.1067\/mob.2001.117416_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(99)00019-0","article-title":"Cycle control with oral contraceptives containing 20 \u03bcg of ethinyl estradiol: a multicenter, randomized comparison of levonorgestrel\/ethinyl estradiol (100 \u03bcg\/ 20 \u03bcg) and norethindrone\/ethinyl estradiol (1000 \u03bcg\/20 \u03bcg)","volume":"59","author":"DelConte","year":"1999","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0002-9378(71)90259-6","article-title":"Treatment of menorrhagia","volume":"110","author":"Nilsson","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0010-7824(92)90095-B","article-title":"The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status","volume":"46","author":"Larsson","year":"1992","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0029-7844(00)01029-2","article-title":"Triphasic norgestimate-ethinyl estradiol for treating dysfunctional uterine bleeding","volume":"96","author":"Davis","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1056\/NEJM198703123161102","article-title":"The reduction in risk of ovarian cancer associated with oral-contraceptive use","volume":"316","author":"The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1067\/mob.2001.117416_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/ije\/17.2.263","article-title":"Endometrial cancer and combined oral contraceptives","volume":"17","author":"The WHO Collaborative Study of Neoplasia and Steroid Contraceptives","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.1067\/mob.2001.117416_bib19","first-page":"931","article-title":"Oral contraceptives and endometrial cancer","volume":"82","author":"Jick","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jama.1987.03390060086029","article-title":"Combination oral contraceptive use and the risk of endometrial cancer","volume":"257","author":"The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development","year":"1987","journal-title":"JAMA"},{"key":"10.1067\/mob.2001.117416_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","article-title":"Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives","volume":"152","author":"Ness","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1067\/mob.2001.117416_bib22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/oxfordjournals.aje.a117055","article-title":"A case-control study of oral contraceptive use and invasive epithelial ovarian cancer","volume":"139","author":"Rosenberg","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1067\/mob.2001.117416_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/aje\/152.3.242","article-title":"Oral contraceptive and benign ovarian tumors","volume":"152","author":"Westhoff","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1067\/mob.2001.117416_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1471-0528.1992.tb13733.x","article-title":"Benign ovarian cysts in England and Wales and in the United States","volume":"99","author":"Westhoff","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1067\/mob.2001.117416_bib25","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0002-9378(16)32492-9","article-title":"Noncontraceptive health benefits of oral steroidal contraceptives","volume":"142","author":"Mishell","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00008469-199303000-00007","article-title":"Oral contraceptive use and risk of benign breast disease in a French case-control study of young women","volume":"2","author":"Charreau","year":"1993","journal-title":"Eur J Cancer Prevent"},{"key":"10.1067\/mob.2001.117416_bib27","series-title":"Cancer facts & figures, 2000: selected cancers","author":"American Cancer Society","year":"2001"},{"key":"10.1067\/mob.2001.117416_bib28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00001648-199805000-00014","article-title":"Oral contraceptive use and risk of colorectal cancer","volume":"9","author":"Fernandez","year":"1998","journal-title":"Epidemiology"},{"key":"10.1067\/mob.2001.117416_bib29","first-page":"703","article-title":"Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study","volume":"71","author":"Potter","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1067\/mob.2001.117416_bib30","first-page":"1","article-title":"A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer","volume":"6","author":"Martinez","year":"1997","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1067\/mob.2001.117416_bib31","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/0895-4356(90)90023-I","article-title":"The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis","volume":"43","author":"Spector","year":"1990","journal-title":"J Clin Epidemiol"},{"key":"10.1067\/mob.2001.117416_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ard.55.2.94","article-title":"Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis","volume":"55","author":"Jorgensen","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1067\/mob.2001.117416_bib33","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/0002-9378(90)90668-W","article-title":"Contraception and ectopic pregnancy risk","volume":"163","author":"Franks","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0002-9378(92)91377-M","article-title":"Pelvic inflammatory disease: trends in hospitalizations and office visits, 1979 through 1988","volume":"166","author":"Rolfs","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0010-7824(91)90130-8","article-title":"Type of oral contraceptive in relation to acute, initial episodes of pelvic inflammatory disease","volume":"43","author":"Panser","year":"1991","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib36","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0190-9622(92)70135-3","article-title":"The prevalence of acne on the basis of physical examination","volume":"26","author":"Stern","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mob.2001.117416_bib37","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1A","key":"10.1067\/mob.2001.117416_bib38","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0002-9343(99)80064-3","article-title":"Hormonal correlates of acne and hirsutism","volume":"98","author":"Lucky","year":"1995","journal-title":"Am J Med"},{"key":"10.1067\/mob.2001.117416_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib40","series-title":"Physician's guide to prevention and treatment of osteoporosis","author":"National Osteoporosis Foundation","year":"1998"},{"key":"10.1067\/mob.2001.117416_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1749-6632.1990.tb30341.x","article-title":"Epidemiology of osteoporosis: predicting who is at risk","volume":"592","author":"Melton","year":"1990","journal-title":"Ann NY Acad Sci"},{"key":"10.1067\/mob.2001.117416_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0002-9378(96)70366-6","article-title":"Bone-sparing properties of oral contraceptives","volume":"174","author":"DeCherney","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0002-9378(00)70209-2","article-title":"Oral contraceptives and bone-mineral density: a population-based study","volume":"182","author":"Pasco","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0010-7824(00)00086-X","article-title":"Low-dose oral contraceptives and bone mineral density: an evidence-based analysis","volume":"61","author":"Kuohong","year":"2000","journal-title":"Contraception"},{"issue":"suppl1","key":"10.1067\/mob.2001.117416_bib45","first-page":"7","article-title":"Oral contraception: past, present, and future perspectives","volume":"36","author":"Mishell","year":"1992","journal-title":"Int J Fertil"},{"key":"10.1067\/mob.2001.117416_bib46","series-title":"Cardiovascular disease and steroid hormone contraception: report of a WHO Scientific Group","author":"WHO Scientific Group on Cardiovascular Disease and Steroid Hormone Contraception","year":"1998"},{"key":"10.1067\/mob.2001.117416_bib47","first-page":"1","article-title":"Oral contraceptives and nonfatal vascular disease","volume":"66","author":"Porter","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1067\/mob.2001.117416_bib48","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/01443619509015499","article-title":"The risk of venous thromboembolism associated with low oestrogen oral contraceptives","volume":"15","author":"Farmer","year":"1995","journal-title":"J Obstet Gynaecol"},{"key":"10.1067\/mob.2001.117416_bib49","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1067\/mob.2001.117416_bib50","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study","volume":"346","author":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1067\/mob.2001.117416_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0010-7824(96)00112-6","article-title":"with the Transnational Research Group on Oral Contraceptives and the Health of Young Women. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research","volume":"54","author":"Lewis","year":"1996","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ije\/21.1.48","article-title":"Risk factors for fatal venous thromboembolism in young women: a case-control study","volume":"21","author":"Thorogood","year":"1992","journal-title":"Int J Epidemiol"},{"key":"10.1067\/mob.2001.117416_bib53","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease","volume":"346","author":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1995","journal-title":"Lancet"},{"key":"10.1067\/mob.2001.117416_bib54","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1067\/mob.2001.117416_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bmj.312.7023.83","article-title":"Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study","volume":"312","author":"Spitzer","year":"1996","journal-title":"BMJ"},{"key":"10.1067\/mob.2001.117416_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(96)07496-X","article-title":"Population-based study of risk of venous thromboembolism associated with various oral contraceptives","volume":"349","author":"Farmer","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mob.2001.117416_bib57","series-title":"FDA Talk Paper. Oral contraceptives and risk of blood clots. T95-61","year":"1995"},{"key":"10.1067\/mob.2001.117416_bib58","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(05)80081-9","article-title":"Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study","volume":"342","author":"Koster","year":"1993","journal-title":"Lancet"},{"key":"10.1067\/mob.2001.117416_bib59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","article-title":"Resistance to activated protein C as a basis for venous thrombosis","volume":"330","author":"Svensson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1067\/mob.2001.117416_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bmj.298.6667.165","article-title":"Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraceptive study","volume":"298","author":"Croft","year":"1989","journal-title":"BMJ"},{"key":"10.1067\/mob.2001.117416_bib61","series-title":"Implications of smoking and contraception use","first-page":"3","author":"Castelli","year":"1996"},{"key":"10.1067\/mob.2001.117416_bib62","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/oxfordjournals.aje.a115592","article-title":"Oral contraceptive use and the risk of myocardial infarction","volume":"131","author":"Rosenberg","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1067\/mob.2001.117416_bib63","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international, multicentre, case-control study","volume":"349","author":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mob.2001.117416_bib64","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/01.STR.29.11.2277","article-title":"Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies","volume":"29","author":"Schwartz","year":"1998","journal-title":"Stroke"},{"key":"10.1067\/mob.2001.117416_bib65","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives","volume":"335","author":"Petitti","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1067\/mob.2001.117416_bib66","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(95)12393-8","article-title":"Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study","volume":"348","author":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1996","journal-title":"Lancet"},{"key":"10.1067\/mob.2001.117416_bib67","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/bmj.318.7175.13","article-title":"Migraine and stroke in young women: case-control study","volume":"318","author":"Chang","year":"1999","journal-title":"BMJ"},{"key":"10.1067\/mob.2001.117416_bib68","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(95)12394-6","article-title":"Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study","volume":"348","author":"WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","year":"1996","journal-title":"Lancet"},{"issue":"suppl 3","key":"10.1067\/mob.2001.117416_bib69","doi-asserted-by":"crossref","first-page":"i","DOI":"10.1016\/S0010-7824(15)30001-9","article-title":"Oral contraceptives and breast cancer\u2014resolution emerges","volume":"54","author":"Westhoff","year":"1996","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib70","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative breast cancer reanalysis of individual data on 53 297 women with and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Lancet"},{"issue":"suppl","key":"10.1067\/mob.2001.117416_bib71","first-page":"1S","article-title":"Breast cancer and hormonal contraceptives: further results","volume":"54","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","journal-title":"Contraception"},{"key":"10.1067\/mob.2001.117416_bib72","first-page":"33","article-title":"Hormonal contraception and breast cancer: accounting for age at diagnosis","volume":"17","author":"Collins","year":"1995","journal-title":"J Soc Obstet Gynecol Can"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937801151367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937801151367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T22:51:05Z","timestamp":1576450265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937801151367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0002937801151367"],"URL":"https:\/\/doi.org\/10.1067\/mob.2001.117416","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}